| BE0198-1MG
| InVivoMAb anti-mouse/human IL-5
| 1 mg
| BioXCell
| in vivo IL-5 neutralization, in vivo eosinophil de
|
| Rat
| Human, Mouse
| Solicitar Precio
| Solicitar
|
| BE0243-50MG
| InVivoMAb anti-mouse IL-1?
| 50 mg
| BioXCell
| in vivo IL-1? neutralization, in vitro IL-1? neutr
|
| Armenian Hamster
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0193-1MG
| InVivoMAb anti-human PD-1 (CD279)
| 1 mg
| BioXCell
| in vivo PD-1 blockade in humanized mice, Flow cyto
|
| Mouse
| Human
| Solicitar Precio
| Solicitar
|
| BE0206-25MG
| InVivoMAb anti-mouse F4/80
| 25 mg
| BioXCell
| in vivo Monocyte/Macrophage depletion, Functional
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0288-100MG
| InVivoMAb anti-human CD4
| 100 mg
| BioXCell
| in vitro CD4 blockade, in vitro blocking of CD4+ T
|
| Mouse
| Human
| Solicitar Precio
| Solicitar
|
| BE0234-25MG
| InVivoMAb anti-human IL-12 p70
| 25 mg
| BioXCell
| Functional assays, ELISA, Flow cytometry
|
| Rat
| Human
| Solicitar Precio
| Solicitar
|
| BE0220-50MG
| InVivoMAb anti-mouse CD209b (SIGN-R1)
| 50 mg
| BioXCell
| in vivo SIGN-R1 blockade, Immunohistochemistry (fr
|
| Armenian Hamster
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0204-25MG
| InVivoMAb anti-mouse CSF1
| 25 mg
| BioXCell
| in vivo CSF1 neutralization
|
| Rat
|
| Solicitar Precio
| Solicitar
|
| BE0260-50MG
| InVivoMAb Armenian hamster IgG isotype control, anti-glutathione S-transferase
| 50 mg
| BioXCell
|
|
| Armenian Hamster
|
| Solicitar Precio
| Solicitar
|
| BE0270-1MG
| InVivoMAb anti-mouse CD47 (IAP)
| 1 mg
| BioXCell
| in vivo CD47 blockade, in vitro CD47 blockade, Imm
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0231-25MG
| InVivoMAb anti-human CD3
| 25 mg
| BioXCell
| in vivo T cell depletion in humanized mice, ex viv
|
| Mouse
| Human
| Solicitar Precio
| Solicitar
|
| BE0232-25MG
| InVivoMAb anti-mouse CD29
| 25 mg
| BioXCell
| in vitro CD29 neutralization, Immunofluorescence,
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0231-1MG
| InVivoMAb anti-human CD3
| 1 mg
| BioXCell
| in vivo T cell depletion in humanized mice, ex viv
|
| Mouse
| Human
| Solicitar Precio
| Solicitar
|
| BE0251-100MG
| InVivoMAb anti-rat IgG2a
| 100 mg
| BioXCell
| Immunofluorescence, ELISA, Flow cytometry
|
| Mouse
| Rat
| Solicitar Precio
| Solicitar
|
| BE0198-50MG
| InVivoMAb anti-mouse/human IL-5
| 50 mg
| BioXCell
| in vivo IL-5 neutralization, in vivo eosinophil de
|
| Rat
| Human, Mouse
| Solicitar Precio
| Solicitar
|
| BE0246-100MG
| InVivoMAb anti-mouse/rat IL-1?
| 100 mg
| BioXCell
| in vivo IL-1? neutralization, in vitro IL-1? neutr
|
| Armenian Hamster
| Mouse, Rat
| Solicitar Precio
| Solicitar
|
| BE0234-1MG
| InVivoMAb anti-human IL-12 p70
| 1 mg
| BioXCell
| Functional assays, ELISA, Flow cytometry
|
| Rat
| Human
| Solicitar Precio
| Solicitar
|
| BE0236-1MG
| InVivoMAb anti-mouse Podoplanin (gp38)
| 1 mg
| BioXCell
| in vivo PDPN blockade, in vitro PDPN blockade, Imm
|
| Syrian Hamster
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0245-50MG
| InVivoMAb anti-human IFN?
| 50 mg
| BioXCell
| Flow cytometry
|
| Mouse
| Human
| Solicitar Precio
| Solicitar
|
| BE0294-25MG
| InVivoMAb anti-mouse E-selectin (CD62E)
| 25 mg
| BioXCell
| in vivo E-selectin blockade, in vitro E-selectin b
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0243-100MG
| InVivoMAb anti-mouse IL-1?
| 100 mg
| BioXCell
| in vivo IL-1? neutralization, in vitro IL-1? neutr
|
| Armenian Hamster
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0241-5MG
| InVivoMAb anti-mouse IFNAR-1
| 5 mg
| BioXCell
| in vivo IFNAR-1 blockade, in vitro IFNAR-1 blockad
|
| Mouse
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0291-25MG
| InVivoMAb anti-human/monkey CD28
| 25 mg
| BioXCell
| in vitro T cell stimulation/activation, Immunoprec
|
| Mouse
| Human, Monkey
| Solicitar Precio
| Solicitar
|
| BE0223-50MG
| InVivoMAb anti-mouse CD8? (Lyt 3.2)
| 50 mg
| BioXCell
| in vivo CD8+ T cell depletion, in vitro CD8 blocka
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0191-25MG
| InVivoMAb anti-mouse RANKL (CD254)
| 25 mg
| BioXCell
| in vivo RANKL blockade
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0210-50MG
| InVivoMAb anti-mouse BTLA (CD272)
| 50 mg
| BioXCell
| Flow cytometry
|
| Mouse
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0241-1MG
| InVivoMAb anti-mouse IFNAR-1
| 1 mg
| BioXCell
| in vivo IFNAR-1 blockade, in vitro IFNAR-1 blockad
|
| Mouse
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0249-1MG
| InVivoMAb anti-mouse CXCR3 (CD183)
| 1 mg
| BioXCell
| in vivo CXCR3 neutralization, Flow cytometry
|
| Armenian Hamster
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0281-5MG
| InVivoMAb anti-human CD19
| 5 mg
| BioXCell
| Flow cytometry, Functional assays, Immunofluoresce
|
| Mouse
| Human
| Solicitar Precio
| Solicitar
|
| BE0209-25MG
| InVivoMAb anti-mouse CD73
| 25 mg
| BioXCell
| in vivo CD73 blockade, in vitro CD73 blockade
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0251-25MG
| InVivoMAb anti-rat IgG2a
| 25 mg
| BioXCell
| Immunofluorescence, ELISA, Flow cytometry
|
| Mouse
| Rat
| Solicitar Precio
| Solicitar
|
| BE0258-100MG
| InVivoMAb anti-mouse IL-21R
| 100 mg
| BioXCell
| in vivo IL-21R blockade
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0259-1MG
| InVivoMAb anti-mouse GM-CSF
| 1 mg
| BioXCell
| in vivo GM-CSF neutralization, in vitro GM-CSF neu
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0273-5MG
| InVivoMAb anti-mouse PD-1 (CD279)
| 5 mg
| BioXCell
| in vivo blocking of PD-1/PD-L signaling, in vitro
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0192-1MG
| InVivoMAb anti-human CD11a (LFA-1?)
| 1 mg
| BioXCell
| Functional assays, Flow cytometry
|
| Mouse
| Human
| Solicitar Precio
| Solicitar
|
| BE0218-5MG
| InVivoMAb anti-mouse Galectin-9
| 5 mg
| BioXCell
| in vivo Galectin-9 blockade in vitro Galectin-9 bl
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0292-5MG
| InVivoMAb anti-human/monkey CD40L (CD154)
| 5 mg
| BioXCell
| in vitro blocking of CD40/CD40L signaling, in vivo
|
| Mouse
| Human, Monkey
| Solicitar Precio
| Solicitar
|
| BE0204-50MG
| InVivoMAb anti-mouse CSF1
| 50 mg
| BioXCell
| in vivo CSF1 neutralization
|
| Rat
|
| Solicitar Precio
| Solicitar
|
| BE0262-5MG
| InVivoMAb anti-human CD44
| 5 mg
| BioXCell
| in vivo CD44 blockade in xenografts, in vitro CD44
|
| Rat
| Human
| Solicitar Precio
| Solicitar
|
| BE0273-1MG
| InVivoMAb anti-mouse PD-1 (CD279)
| 1 mg
| BioXCell
| in vivo blocking of PD-1/PD-L signaling, in vitro
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0262-50MG
| InVivoMAb anti-human CD44
| 50 mg
| BioXCell
| in vivo CD44 blockade in xenografts, in vitro CD44
|
| Rat
| Human
| Solicitar Precio
| Solicitar
|
| BE0271-50MG
| InVivoMAb anti-mouse CD132 (common ? chain)
| 50 mg
| BioXCell
| in vivo ?c blockade, Functional assays, Immunoprec
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0285-25MG
| InVivoMAb anti-human PD-L1 (B7-H1)
| 25 mg
| BioXCell
| in vitro PD-L1 blockade, Functional assays, Immuno
|
| Mouse
| Human
| Solicitar Precio
| Solicitar
|
| BE0282-25MG
| InVivoMab anti-mouse IL-3
| 25 mg
| BioXCell
| in vivo IL-3 neutralization, in vitro IL-3 neutral
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0276-5MG
| InVivoMAb anti-human/monkey CD20
| 5 mg
| BioXCell
| in vivo B cell depletion in hCD20 Tg mice, Immunoh
|
| Mouse
| Human, Monkey
| Solicitar Precio
| Solicitar
|
| BE0233-100MG
| InVivoMAb anti-mouse IL-12 p75
| 100 mg
| BioXCell
| in vivo IL-12p75 neutralization, ELISA
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0290-5MG
| InVivoMAb rat IgG1 Isotype control, anti-trinitrophenol
| 5 mg
| BioXCell
|
|
| Rat
| Rat
| Solicitar Precio
| Solicitar
|
| BE0191-50MG
| InVivoMAb anti-mouse RANKL (CD254)
| 50 mg
| BioXCell
| in vivo RANKL blockade
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0211-50MG
| InVivoMAb anti-human CD1a
| 50 mg
| BioXCell
| in vitro CD1a blockade, Flow cytometry
|
| Mouse
| Human
| Solicitar Precio
| Solicitar
|
| BE0248-50MG
| InVivoMAb anti-human CD28
| 50 mg
| BioXCell
| in vitro T cell stimulation/activation
|
| Mouse
| Human
| Solicitar Precio
| Solicitar
|